Transcriptomics

Dataset Information

0

Cyanidin-3-rutinoside(C3R) Attenuates Free Fatty Acid-Induced Hepatic Lipid Accumulation in HepG2 Cells


ABSTRACT: Non-alcoholic fatty liver disease (NAFLD) is characteristic by pathological lipid accumulation in hepatocytes. This study investigates how Cyanidin-3-rutinoside(C3R), a natural anthocyanin with antioxidant and metabolic regulatory properties, counteracts this process. In a free fatty acid (FFA)-induced HepG2 steatosis model, C3R significantly reduced intracellular triglycerides, total cholesterol, and LDL-C levels, suppressed lipid droplet formation, and alleviated oxidative stress by enhancing SOD/CAT activities and GSH content while lowering MDA and ROS. RNA-seq analysis revealed that C3R reversed FFA-induced transcriptomic alterations. Mechanistically, C3R inhibited SREBP2-mediated cholesterol synthesis, activated the PCSK9/LDLR pathway to promote cholesterol clearance, and upregulated PPARγ-dependent CYP7A1 expression to stimulate bile acid synthesis from cholesterol. C3R also enhanced autophagic flux, facilitating lipid droplet degradation. Molecular docking confirmed high-affinity binding of C3R to INSIG1, PCSK9, and PPARγ, with hydroxyl groups forming specific hydrogen bonds at active sites, supporting direct target engagement. These findings establish a multi-targeted mechanism for C3R in ameliorating hepatic steatosis and provide a molecular basis for anthocyanin-mediated regulation of lipid metabolism.

ORGANISM(S): Homo sapiens

PROVIDER: GSE316562 | GEO | 2026/01/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
GSE316562_processed_data_file.xls.gz Xls
Items per page:
1 - 2 of 2

Similar Datasets

2025-12-31 | GSE267113 | GEO
2021-08-07 | GSE181610 | GEO
2021-08-05 | GSE181481 | GEO
2023-09-22 | GSE240886 | GEO
2023-08-09 | GSE225859 | GEO
2023-05-31 | GSE205428 | GEO
2025-09-15 | PXD063072 | Pride
2023-11-29 | GSE236364 | GEO
2020-07-08 | GSE139015 | GEO
2019-01-29 | GSE125777 | GEO